Drug Shortage Report for DOXEPIN
Report ID | 13312 |
Drug Identification Number | 02049996 |
Brand name | APO-DOXEPIN |
Common or Proper name | DOXEPIN |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | DOXEPIN |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | N06AA |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-06-19 |
Estimated end date | 2017-06-30 |
Actual end date | 2017-06-30 |
Shortage status | Resolved |
Updated date | 2017-07-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-07-04 | French | Compare |
v6 | 2017-07-04 | English | Compare |
v5 | 2017-07-04 | French | Compare |
v4 | 2017-07-04 | English | Compare |
v3 | 2017-06-20 | English | Compare |
v2 | 2017-06-19 | French | Compare |
v1 | 2017-06-19 | English | Compare |
Showing 1 to 7 of 7